Papavassiliou AG

ORCID: 0000-0001-5803-4527 · 2 papers in corpus

2024

CA-125:CA72-4 ratio - towards a promising cost-effective tool in ovarian cancer diagnosis and monitoring of post-menopausal women under hormone treatment.

Journal of ovarian research ·doi:10.1186/s13048-024-01487-0

Ovarian cancer (OC) is the most lethal gynecological cancer in the developed world. Most cases are diagnosed at late stage III-IV with a very low 5-year overall survival rate. Several studies revealed an elevated risk of OC in users of horm…

other 2010

Atypical induction of the unfolded protein response by mifepristone

Endocrine ·doi:10.1007/s12020-010-9362-0

Mifepristone is a synthetic progesterone antagonist that is being used widely for the treatment of various conditions such as endometriosis, glaucoma, meningiomas, breast, ovarian and prostate cancer, as well as for research purposes, in th…